INMB Receives MHRA Alignment
INmune Bio receives MHRA written alignment supporting planned 2026 UK conditional marketing authorization application for CORDStrom in RDEB
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.